+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopsy Guidance Systems Market Size, Share & Trends Analysis Report By Product (Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5390586
The global biopsy guidance systems market size is expected to reach USD 1.58 billion by 2030, according to a new report. The market is expected to grow at a CAGR of 6.1% from 2024 to 2030. The increasing prevalence of cancer, rise in the geriatric population, growing demand for non-invasive procedures, technological innovations, a rising number of government initiatives, and impact of COVID-19 are the key driving factors for the market.

A biopsy is one of the most prominent procedures for diagnosing cancer amongst other chronic diseases, and it is commonly employed in the diagnosis of breast, brain, skin, and prostate cancer. The increasing prevalence of cancer is a major factor responsible for market growth. For instance, according to Cancer.org, in 2021, around 1.9 million new cancer cases are expected to be diagnosed in the US. Since the biopsy guidance system is one of the major requirements for the initial diagnosis of cancer, thus, rising number of cancer cases is anticipated to propel market growth over the forecast period

Furthermore, there is a rising preference for minimally invasive biopsy treatments in the market. During the forecast period, several types of technologies and products including robot-assisted biopsy guidance systems, needle-based biopsy guns, and vacuum-assisted core biopsy systems, are expected to expand rapidly. For instance, in March 2021, IZI Medical Products, LLC launched Quick-Core Auto Biopsy System for soft tissue biopsy. It is a lightweight, completely automatic biopsy device and provides reliability, quality, and accuracy. Additionally, rising awareness of breast cancer treatment and diagnosis will further boost market growth over the forecast period.

Biopsy Guidance Systems Market Report Highlights

  • The stereotactic guided biopsy dominated the market and accounted for a share of 39.9% in 2023
  • The brain biopsy section accounted for the largest market revenue share in 2023. Brain biopsy is considered the most reliable method to diagnose brain tumors that cannot be surgically removed.
  • The healing centers segment dominated the industry and held the largest revenue share in 2023. It can be attributed to increased adoption of biopsy direction frameworks in clinics.
  • North America biopsy guidance system market dominated the market and accounted for revenue share of 45.4% in 2023.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biopsy Guidance Systems Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Biopsy Guidance Systems Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Biopsy Guidance Systems Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Biopsy Guidance Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Stereotactic Guided Biopsy
4.3.1. Stereotactic Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Ultrasound Guided Biopsy
4.4.1. Ultrasound Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. MRI Guided Biopsy
4.5.1. MRI Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Biopsy Guidance Systems Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biopsy Guidance Systems Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Brain Biopsy
5.3.1. Brain Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Breast Biopsy
5.4.1. Breast Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Biopsy Guidance Systems Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Biopsy Guidance Systems Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals
6.3.1. Biopsy Guidance Systems In Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Specialty Clinics
6.4.1. Biopsy Guidance Systems In Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Diagnostic Centers
6.5.1. Biopsy Guidance Systems In Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Research and Academic Institutes
6.6.1. Biopsy Guidance Systems for Research and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Biopsy Guidance Systems Market: Regional Estimates & Trend Analysis
7.1. Biopsy Guidance Systems Market Share, By Region, 2023 & 2030 (USD Billion)
7.2. North America
7.2.1. North America Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Australia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Brazil Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. South Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Becton, Dickinson, and Company
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Hologic, Inc.
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Devicor Medical Products, Inc.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. B. Braun Melsungen AG
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. ARGON MEDICAL
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Boston Scientific Corporation
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. INRAD Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Cook Medical
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. PLANMED OY
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives

Companies Mentioned

  • Becton, Dickinson, and Company
  • Hologic, Inc.
  • Devicor Medical Products, Inc.
  • B. Braun Melsungen AG
  • ARGON MEDICAL
  • Boston Scientific Corporation
  • INRAD Inc.
  • Cook Medical
  • PLANMED OY

Methodology

Loading
LOADING...

Table Information